Lifetime Cost-Effectiveness Analysis of Large-Bore Mechanical Thrombectomy Versus Catheter-Directed Thrombolysis for Intermediate-Risk Pulmonary Embolism in the United States

Tuesday, March 10, 2026

8:51 AM - 8:59 AM EST

Location: International Ballroom Center

Speaker(s)

Samuel Horr, MD

Interventional Cardiologist
Centennial Medical Center
Nashville, Tennessee, United States

Disclosure(s): Abbott Labs: Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing); Edwards Lifesciences LLC: Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing); Inari Medical: Consulting Fees (e.g., advisory boards) (Ongoing); Inquis Medical: Consulting Fees (e.g., advisory boards) (Ongoing)

Disclosure(s):

Samuel Horr, MD: Abbott Labs: Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing); Edwards Lifesciences LLC: Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing); Inari Medical: Consulting Fees (e.g., advisory boards) (Ongoing); Inquis Medical: Consulting Fees (e.g., advisory boards) (Ongoing)